WuXi AppTec’s 100% Stock Rally Defies Geopolitical Headwinds

WuXi AppTec's stock price increased substantially following the Pentagon's designation of the company as a Chinese military company in 2025. Some U.S. clients reduced or ended contracts with the firm after the designation. Investors continued purchasing the stock, citing the company's role in manufacturing drugs for obesity, cancer, and other conditions.

Next story